Overview
Qualitative or quantitative defects of tropomyosin refer to a group of rare inherited conditions in which the tropomyosin proteins in muscle cells are either abnormal in structure (qualitative defect) or present in reduced or increased amounts (quantitative defect). Tropomyosins are proteins that play a key role in regulating how muscles contract. They are found along the thin filaments of muscle fibers and help control the interaction between actin and myosin, the two main proteins responsible for muscle movement. When tropomyosin does not work properly, it can lead to various forms of muscle disease, most commonly nemaline myopathy and other congenital myopathies. Patients may experience muscle weakness that can range from mild to severe, low muscle tone (hypotonia), difficulty breathing, feeding problems in infancy, and delayed motor milestones such as sitting or walking. In some cases, the heart muscle can also be affected, leading to cardiomyopathy. Treatment is currently supportive and focuses on managing symptoms. This may include physical therapy to maintain muscle strength and flexibility, respiratory support for breathing difficulties, nutritional support for feeding problems, and cardiac monitoring if the heart is involved. There is no cure at this time, but ongoing research into gene therapy and other approaches offers hope for future treatments. Early diagnosis through genetic testing and a multidisciplinary care team can significantly improve quality of life.
Key symptoms:
Muscle weaknessLow muscle tone (floppiness) in infantsDifficulty breathingFeeding difficulties in babiesDelayed motor milestones like sitting or walkingThin or slender muscle bulkFacial muscle weaknessDifficulty swallowingScoliosis or curved spineJoint contractures (stiff joints)Fatigue and low energyHeart muscle problems (cardiomyopathy)Foot deformities such as high arches or flat feetFrequent respiratory infections
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Qualitative or quantitative defects of tropomyosin.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Qualitative or quantitative defects of tropomyosin at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Qualitative or quantitative defects of tropomyosin.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Qualitative or quantitative defects of tropomyosin.
Community
No community posts yet. Be the first to share your experience with Qualitative or quantitative defects of tropomyosin.
Start the conversation →Latest news about Qualitative or quantitative defects of tropomyosin
No recent news articles for Qualitative or quantitative defects of tropomyosin.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific tropomyosin gene mutation does my child or I have, and what does it mean for the expected disease course?,How often should breathing and heart function be monitored?,What physical therapy program would be most beneficial?,Are there any clinical trials or research studies we could participate in?,What emergency signs should I watch for, and what is the plan if breathing worsens?,Should other family members be tested for this genetic change?,What support services and resources are available for our family?
Common questions about Qualitative or quantitative defects of tropomyosin
What is Qualitative or quantitative defects of tropomyosin?
Qualitative or quantitative defects of tropomyosin refer to a group of rare inherited conditions in which the tropomyosin proteins in muscle cells are either abnormal in structure (qualitative defect) or present in reduced or increased amounts (quantitative defect). Tropomyosins are proteins that play a key role in regulating how muscles contract. They are found along the thin filaments of muscle fibers and help control the interaction between actin and myosin, the two main proteins responsible for muscle movement. When tropomyosin does not work properly, it can lead to various forms of muscl